What analysts say:
- Buy, sell, or hold?: Analysts think investors should stand pat on Scotts Miracle-Gro, with eight out of 11 analysts rating it hold.
- Revenue forecasts: On average, analysts predict $205.6 million in revenue this quarter. That would represent a decline of 10.7% from the year-ago quarter.
- Wall Street earnings expectations: The average analyst estimate is a loss of $1.22 per share. Estimates range from a loss of $1.25 to a loss of $1.20.
What our community says:
CAPS All-Stars are in strong support of the stock, with 90.8% awarding it an outperform rating. The greater community concurs with the All-Stars, as 86.8% give it a rating of outperform. Fools are impressed with Scotts Miracle-Gro and haven't been shy with their opinions lately, logging 131 posts in the past 30 days. Despite the majority sentiment in favor of Scotts Miracle-Gro, the stock has a middling CAPS rating of three out of five stars.
Revenue has fallen in the past two quarters. The company's gross margin shrank by 7.9 percentage points in the last quarter. Revenue fell 12.3% while cost of sales fell 2.5% to $326.1 million from a year earlier.
For all our Scotts Miracle-Gro-specific analysis, including earnings and beyond, add Scotts Miracle-Gro to My Watchlist.
Motley Fool newsletter services have recommended buying shares of Scotts Miracle-Gro. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.Earnings estimates provided by Zacks.